JP2023540506A5 - - Google Patents
Info
- Publication number
- JP2023540506A5 JP2023540506A5 JP2023514771A JP2023514771A JP2023540506A5 JP 2023540506 A5 JP2023540506 A5 JP 2023540506A5 JP 2023514771 A JP2023514771 A JP 2023514771A JP 2023514771 A JP2023514771 A JP 2023514771A JP 2023540506 A5 JP2023540506 A5 JP 2023540506A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- lumateperone
- cocrystal
- diffraction pattern
- powder diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026060121A JP2026117004A (ja) | 2020-09-04 | 2026-04-01 | 新規の塩、結晶および共結晶 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063075019P | 2020-09-04 | 2020-09-04 | |
| US63/075,019 | 2020-09-04 | ||
| PCT/US2021/071366 WO2022051770A2 (en) | 2020-09-04 | 2021-09-03 | Novel salts, crystals, and co-crystals |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026060121A Division JP2026117004A (ja) | 2020-09-04 | 2026-04-01 | 新規の塩、結晶および共結晶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540506A JP2023540506A (ja) | 2023-09-25 |
| JP2023540506A5 true JP2023540506A5 (cg-RX-API-DMAC7.html) | 2024-09-11 |
Family
ID=80492079
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514771A Pending JP2023540506A (ja) | 2020-09-04 | 2021-09-03 | 新規の塩、結晶および共結晶 |
| JP2026060121A Pending JP2026117004A (ja) | 2020-09-04 | 2026-04-01 | 新規の塩、結晶および共結晶 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026060121A Pending JP2026117004A (ja) | 2020-09-04 | 2026-04-01 | 新規の塩、結晶および共結晶 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230312573A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4208434A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023540506A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230104121A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116113622A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021338439A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3186537A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL300886A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023002468A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022051770A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3600325A4 (en) | 2017-03-24 | 2021-01-06 | Intra-Cellular Therapies, Inc. | UNIQUE COMPOSITIONS AND PROCESSES |
| WO2019178484A1 (en) | 2018-03-16 | 2019-09-19 | Intra-Cellular Therapies, Inc. | Novel methods |
| SMT202600133T1 (it) | 2018-03-23 | 2026-05-12 | Intra Cellular Therapies Inc | Composti organici |
| US12414948B2 (en) | 2022-05-18 | 2025-09-16 | Intra-Cellular Therapies, Inc. | Methods |
| US20250352469A1 (en) | 2024-05-16 | 2025-11-20 | Intra-Cellular Therapies, Inc. | Novel compositions, devices, and methods |
| CN118566395B (zh) * | 2024-08-02 | 2024-10-25 | 则正(济南)生物科技有限公司 | 测定甲苯磺酸卢美哌隆口崩片中杂质含量的方法、应用和系统 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL281050B2 (en) * | 2016-03-25 | 2023-04-01 | Intra Cellular Therapies Inc | A controlled or delayed release pharmaceutical preparation containing a deuterated compound |
| WO2017172811A1 (en) * | 2016-03-28 | 2017-10-05 | Intra-Cellular Therapies, Inc. | Novel co-crystals |
| EP3600325A4 (en) * | 2017-03-24 | 2021-01-06 | Intra-Cellular Therapies, Inc. | UNIQUE COMPOSITIONS AND PROCESSES |
| WO2018189646A1 (en) * | 2017-04-10 | 2018-10-18 | Dr. Reddy's Laboratories Limited | AMORPHOUS FORM AND SOLID DISPERSIONS OF LUMATEPERONE p-TOSYLATE |
| WO2019067591A1 (en) * | 2017-09-26 | 2019-04-04 | Intra-Cellular Therapies, Inc. | NEW SALTS AND CRYSTALS |
| BR112020024885A2 (pt) * | 2018-06-06 | 2021-03-09 | Intra-Cellular Therapies, Inc. | Novos sais e cristais |
| RS67906B1 (sr) * | 2018-06-11 | 2026-04-30 | Intra Cellular Therapies Inc | Sinteza supstituisanih heterociklično fuzionisanih gama-karbolina |
| US12144808B2 (en) * | 2018-08-29 | 2024-11-19 | Intra-Cellular Therapies, Inc. | Compositions and methods |
| WO2020112941A2 (en) * | 2018-11-27 | 2020-06-04 | Teva Czech Industries S.R.O | Solid state forms of lumateperone salts and processes for preparation of lumateperone and salts thereof |
| EP4134101A1 (en) * | 2019-07-07 | 2023-02-15 | Intra-Cellular Therapies, Inc. | Deuterated lumateperone for the treatment of the bipolar ii disorder |
| JP2022549335A (ja) * | 2019-09-25 | 2022-11-24 | イントラ-セルラー・セラピーズ・インコーポレイテッド | 新規方法 |
-
2021
- 2021-09-03 IL IL300886A patent/IL300886A/en unknown
- 2021-09-03 AU AU2021338439A patent/AU2021338439A1/en active Pending
- 2021-09-03 US US18/043,959 patent/US20230312573A1/en active Pending
- 2021-09-03 KR KR1020237010822A patent/KR20230104121A/ko active Pending
- 2021-09-03 JP JP2023514771A patent/JP2023540506A/ja active Pending
- 2021-09-03 EP EP21865304.6A patent/EP4208434A4/en active Pending
- 2021-09-03 CN CN202180054461.5A patent/CN116113622A/zh active Pending
- 2021-09-03 CA CA3186537A patent/CA3186537A1/en active Pending
- 2021-09-03 WO PCT/US2021/071366 patent/WO2022051770A2/en not_active Ceased
- 2021-09-03 MX MX2023002468A patent/MX2023002468A/es unknown
-
2026
- 2026-04-01 JP JP2026060121A patent/JP2026117004A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3621707B2 (ja) | ピリドン―縮合したアザ二環式―またはシチシン誘導体、その製法および嗜癖治療におけるその用途 | |
| JP2021527043A5 (cg-RX-API-DMAC7.html) | ||
| JP4764911B2 (ja) | メタニコチン化合物のヒドロキシ安息香酸塩 | |
| JP4477097B2 (ja) | 中枢神経系障害の治療のための(2s)−(4e)−n−メチル−5−[3−(5−イソプロポキシピリジン)イル]−4−ペンテン−2−アミンの多形形態 | |
| JP6592512B2 (ja) | 三環式アトロプ異性体の化合物 | |
| JP2007528396A (ja) | Hivインテグラーゼ阻害薬 | |
| JP2005509679A (ja) | 4−(1,3,4−チアジアゾール−2−イル)−1,4−ジアザビシクロ−[3.2.2]ノナン誘導体、それらの製造およびそれらの治療的使用 | |
| JP2014074067A (ja) | メシル酸イマチニブのf、g、h、iおよびk結晶形 | |
| KR102142797B1 (ko) | 피리디닐아미노피리미딘 유도체의 메실레이트 염의 결정질 형태, 그의 제조 방법, 및 그의 용도 | |
| HUE034460T2 (en) | Substituted tetrahydrocarbazole and carbazole carboxamide compounds useful as kinase inhibitors | |
| KR20170137738A (ko) | 부프레노르핀의 아세테이트 염 및 부프레노르핀의 제조방법 | |
| JP5134755B2 (ja) | 4−(オキサゾロピリジン−2−イル)−1,4−ジアザビシクロ−[3.2.2]ノナン誘導体、それらの製造と治療的使用 | |
| TW201006813A (en) | Novel compounds | |
| HU197842B (en) | Process for producing pharmaceutical compositions comprising 2-alkoxy-n-(1-azabicyclo/2.2.2/oct-3-yl)-benzamide derivatives | |
| CN112638376B (zh) | 取代的四氢环戊二烯并[c]吡咯、取代的二氢吡咯嗪、其类似物和其使用方法 | |
| US20110306633A1 (en) | Selective m4 receptor antagonist and its medical use | |
| KR100339115B1 (ko) | 결정성3-(4-헥실옥시-1,2,5-티아디아졸-3-일)-1,2,5,6-테트라하이드로-1-메틸피리딘(+)l-하이드로겐타르트레이트,이의제조방법및이를포함하는약제학적조성물 | |
| WO2009053742A2 (en) | Salts of nefopam and their use in therapy | |
| CN117736193B (zh) | 一种氘代稠环化合物及其制备方法与用途 | |
| JP2007269628A (ja) | 医薬化合物の結晶 | |
| US6683089B2 (en) | N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols | |
| JP2005517013A (ja) | N−アリルオキシエチル−1,2,3,4,5,6−ヘキサヒドロ−2,6−メタノ−3−ベンズアゾシン及びその薬剤としての使用 | |
| JP2008195654A (ja) | ベンゾ[b]フラン化合物の新規結晶形 | |
| ES2230369T3 (es) | Fumarato de amlodipina. | |
| HK40047161A (en) | Substituted tetrahydrocyclopenta[c]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same |